|Bid||35.71 x 1200|
|Ask||36.20 x 200|
|Day's Range||35.81 - 36.21|
|52 Week Range||29.83 - 36.21|
|PE Ratio (TTM)||26.33|
|Dividend & Yield||1.28 (3.61%)|
|1y Target Est||N/A|
Pfizer is suing Johnson & Johnson, alleging that it set up contracts to leave Pfizer’s Inflectra out in the cold.
European regulators on Thursday granted market approval for Merck KGaA and Pfizer's immuno-oncology drug Bavencio to treat a rare and aggressive type of skin cancer called Merkel cell carcinoma. In May, ...
Two of the world's largest drugmakers are heading to court over a blockbuster arthritis treatment...